Where collaboration is driven by a deep sense of commitment to learn and share game-changing therapies in ophthalmology, Ophthalmology Innovation Source (OIS) gives the opportunity to network where extraordinary things happen when the right people connect! Join AiViva at OIS as our CEO, Dr. Diane Tang-Liu, as she presents “AIV007 in nAMD and DME Results”…

AiViva attending the 2025 OIS RETINA INNOVATION SUMMIT, located in Long Beach, California. Date of event is July 29, 2025. More information to come.    

We’re excited to announce that AiViva BioPharma will participate in the BIO International Convention 2025, which will take place this June in Boston! With three clinical-stage programs and our proprietary JEL® long-acting injectable platform, AiViva is redefining how therapies are delivered. It focuses drugs precisely where needed, minimizing systemic exposure, and extending duration for up…